NLS Pharmaceutics Stock Forecast - Simple Exponential Smoothing
| NLSP Stock | USD 0.13 0.01 7.14% |
The Simple Exponential Smoothing forecasted value of NLS Pharmaceutics AG on the next trading day is expected to be 0.13 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.77. NLS Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NLS Pharmaceutics stock prices and determine the direction of NLS Pharmaceutics AG's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NLS Pharmaceutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although NLS Pharmaceutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of NLS Pharmaceutics' systematic risk associated with finding meaningful patterns of NLS Pharmaceutics fundamentals over time.
Check out Historical Fundamental Analysis of NLS Pharmaceutics to cross-verify your projections. NLS |
Most investors in NLS Pharmaceutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the NLS Pharmaceutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets NLS Pharmaceutics' price structures and extracts relationships that further increase the generated results' accuracy.
NLS Pharmaceutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for NLS Pharmaceutics AG are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as NLS Pharmaceutics prices get older. NLS Pharmaceutics Simple Exponential Smoothing Price Forecast For the 25th of April
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of NLS Pharmaceutics AG on the next trading day is expected to be 0.13 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.77.Please note that although there have been many attempts to predict NLS Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that NLS Pharmaceutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
NLS Pharmaceutics Stock Forecast Pattern
| Backtest NLS Pharmaceutics | NLS Pharmaceutics Price Prediction | Buy or Sell Advice |
NLS Pharmaceutics Forecasted Value
In the context of forecasting NLS Pharmaceutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. NLS Pharmaceutics' downside and upside margins for the forecasting period are 0 and 7.02, respectively. We have considered NLS Pharmaceutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of NLS Pharmaceutics stock data series using in forecasting. Note that when a statistical model is used to represent NLS Pharmaceutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.5376 |
| Bias | Arithmetic mean of the errors | 0.0067 |
| MAD | Mean absolute deviation | 0.0128 |
| MAPE | Mean absolute percentage error | 0.0481 |
| SAE | Sum of the absolute errors | 0.7671 |
Predictive Modules for NLS Pharmaceutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NLS Pharmaceutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NLS Pharmaceutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for NLS Pharmaceutics
For every potential investor in NLS, whether a beginner or expert, NLS Pharmaceutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NLS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NLS. Basic forecasting techniques help filter out the noise by identifying NLS Pharmaceutics' price trends.View NLS Pharmaceutics Related Equities
| Risk & Return | Correlation |
NLS Pharmaceutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NLS Pharmaceutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NLS Pharmaceutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
NLS Pharmaceutics Market Strength Events
Market strength indicators help investors to evaluate how NLS Pharmaceutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NLS Pharmaceutics shares will generate the highest return on investment. By undertsting and applying NLS Pharmaceutics stock market strength indicators, traders can identify NLS Pharmaceutics AG entry and exit signals to maximize returns.
NLS Pharmaceutics Risk Indicators
The analysis of NLS Pharmaceutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NLS Pharmaceutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nls stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.18 | |||
| Standard Deviation | 6.75 | |||
| Variance | 45.51 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of NLS Pharmaceutics to cross-verify your projections. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for NLS Stock analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is NLS Pharmaceutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NLS Pharmaceutics. If investors know NLS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NLS Pharmaceutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Return On Assets (4.14) | Return On Equity (8.63) |
The market value of NLS Pharmaceutics is measured differently than its book value, which is the value of NLS that is recorded on the company's balance sheet. Investors also form their own opinion of NLS Pharmaceutics' value that differs from its market value or its book value, called intrinsic value, which is NLS Pharmaceutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NLS Pharmaceutics' market value can be influenced by many factors that don't directly affect NLS Pharmaceutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NLS Pharmaceutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NLS Pharmaceutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NLS Pharmaceutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.